期刊文献+

临床白假丝酵母感染状况分析及药物敏感性 被引量:2

The analysis of infection conditions and drug sensitivity on the clinical isolates of Candida albicans
下载PDF
导出
摘要 目的探讨医院内白假丝酵母感染现状及对常用抗真菌药物的敏感性,为临床真菌感染的治疗提供一定的理论依据。方法收集临床真菌感染患者标本,进行菌株的分离、鉴定。分析白假丝酵母标本的来源和科室分布情况,并采用CLSI颁布的微量稀释法进行药物敏感性实验。结果白假丝酵母所占比例高达72.2%,主要来源于呼吸内科(65.6%),以痰标本的真菌分离率最高(86.8%)。药物敏感性实验结果表明,白假丝酵母对两性霉素B(AmB)、氟康唑(FCZ)、5-氟胞嘧啶(5-FC)、伊曲康唑(ICZ)的敏感率依次为100.0%、92.7%、91.4%、64.2%;仅对ICZ表现为耐药,耐药率为1.4%,但药物依赖性敏感高达34.4%。结论临床医生应高度重视医院内真菌感染;根据药物敏感性实验结果,合理用药,既能提高疗效,又可预防耐药性的产生。 Objective To analyze the current conditions of nosocomial infection on Candida albicans and the susceptibility to common antifungal drugs,in order to provide a theoretical basis for the treatment of fungal infection.Methods The specimens of clinical infection of fungi were collected and the isolates were identified.Then the cases of Candida albicans were analyzed according to the source of samples and division distribution.Microdilution susceptibility testing was promulgated by CLSI.Results The infection rate of Candida albicans was as high as 72.2%.The infection rate of respiratory system was the most high(65.6%).The highest positive rate of sputum specimens was 86.8%.The results of susceptibility testing presented the sensitive rates of Candida albicans to AmB, FCZ,5-FC,ICZ were followed by 100%,92.7%,91.4%,64.2%;ICZ showed only resistance and the resistant rate to ICZ was 1.4%,but the sensitive rate of drug dependence was up to 34.4%.Conclusions The clinicians should think highly of the nosocomial fungal infections and use antifungal drugs on the rules of rational application.This will help to improve the curative effect and prevent drug resistance.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第24期3677-3679,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金重大国际合作资助项目(30910103903) 吉林省科技发展计划重点资助项目(20080444-2)
关键词 微量稀释法 白假丝酵母 最小抑菌浓度 Microdilution susceptibility testing Candida albicans MIC
  • 相关文献

参考文献6

二级参考文献31

共引文献107

同被引文献26

  • 1邱胜丰,潘世扬,顾兵,张美娟,黎青.泌尿系统感染主要病原菌分布及耐药性分析[J].中华临床感染病杂志,2012,5(2):73-76. 被引量:17
  • 2廖万清,顾菊林.深部真菌感染治疗的现状与对策[J].中国感染与化疗杂志,2007,7(2):101-103. 被引量:37
  • 3叶应妩;王毓三;申子瑜.全国临床检验操作规程[M]南京:东南大学出版社,2006754-883.
  • 4Morschhuser J. Regulation of multidrug resistance in pathogenic fungi[J].Fungal Genetics and Biology,2010,(02):94-106.doi:10.1016/j.fgb.2009.08.002.
  • 5Lass F1 rl C. The changing face of epidemiology of invasive fungaI disease in Europe[J]. Mycoses,2009,52(3) :197.
  • 6Ortega M,Marco F,Soriano A,et al. Candida species bloodstream infection:epidemiology and outcome in a single institution from 1991 to 2008[J]. J Hosp Infect,2011,77(2) :157.
  • 7Warnoek DW. Trends in the epidemiology of invasive fungal in- fectiong[J]. Jpn J Med Mycol,2007,48(1) : 1.
  • 8Wang L, Yokoyama K, Miyaji M, et al. Mitochondrial cytochrome b gene analysis of Aspergillus fumigatus and related species[J]. J Clin Microbiol, 2000,38 (4) : 1352.
  • 9Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial blood- stream infections in US hospitals:analysis of 24,179 cases from a prospective nationwide surveillance study[J]. Clin Infect Dis, 2004,39(3) :309.
  • 10Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and out- comes of candidemia in 2019 patients:data from the prospective antifungal therapy alliance registry [J]. Clin Infect Dis, 2009,48 (12), 1695.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部